Workflow
杠杆资金布局
icon
Search documents
成交额超27亿元,公司债ETF(511030)连续5天净流入
Sou Hu Cai Jing· 2025-12-04 01:53
Group 1 - The total scale of credit bond ETFs is 501.9 billion yuan, with a daily increase of 230 million yuan, while the benchmark market-making ETF decreased by 430 million yuan and the sci-tech bond ETF increased by 620 million yuan [1] - The median weighted duration is 3.5 years, and the overall transaction amount is 129 billion yuan, with an average single transaction amount of 6.2 million yuan [1] - The median yield is 1.94%, and the median discount rate is -15.6 basis points, with the benchmark market-making at -29.9 basis points and sci-tech bonds at -11.2 basis points [1] Group 2 - As of December 3, 2025, the company bond ETF (511030) is priced at 106.58 yuan, with a year-to-date increase of 1.41% [2] - The liquidity of the company bond ETF shows an intraday turnover of 10.48% and a transaction volume of 2.713 billion yuan, indicating active market trading [2] - The latest scale of the company bond ETF reaches 25.895 billion yuan, marking a one-year high, with the latest share count at 24.3 million, also a six-month high [2] Group 3 - The company bond ETF has seen continuous net inflows over the past five days, with a maximum single-day net inflow of 139 million yuan, totaling 206 million yuan, averaging 4.1137 million yuan daily [2] - Leveraged funds have been consistently entering the market, with the company bond ETF receiving net purchases of leveraged funds for three consecutive days, peaking at 42.6477 million yuan [2] - The maximum drawdown for the company bond ETF in the past six months is 0.28%, with a relative benchmark drawdown of 0.04% and a recovery period of 29 days [2] Group 4 - The management fee rate for the company bond ETF is 0.15%, and the custody fee rate is 0.05% [3] - The tracking error for the company bond ETF over the past month is 0.010%, closely tracking the China Bond - Medium to High Grade Corporate Bond Spread Factor Index [3] - The index is based on AAA-rated corporate bonds and is adjusted quarterly, providing a benchmark for investment performance in medium to high-grade corporate bonds [3]
科创100指数ETF(588030)、创业板ETF博时(159908)走强涨近1%,市场交投情绪高涨,科技成长风格仍有望占优
Xin Lang Cai Jing· 2025-08-15 02:32
Core Viewpoint - The market is experiencing fluctuations after reaching significant index levels, with a potential for a rebound despite recent adjustments in stock prices [7]. Group 1: Market Performance - As of August 15, 2025, the Sci-Tech Innovation Board 100 Index rose by 0.75%, with notable gains from stocks such as Bozhong Precision (6.35%) and Zhuhai Guanyu (6.09%) [3]. - The ChiNext Index increased by 0.72%, with top performers including Feiliwa (9.79%) and Zhina Compass (7.32%) [6]. - The Shanghai Composite Index reached a high of 3704.77 points but closed down by 0.46%, indicating mixed market sentiment [6]. Group 2: Trading Volume and Liquidity - The trading volume exceeded 2.3 trillion yuan, following a previous record of over 2 trillion yuan, reflecting active market participation [6]. - The turnover rate for the Sci-Tech 100 Index ETF was 0.73%, with a transaction volume of 49.77 million yuan [3]. - The ChiNext ETF saw a turnover rate of 1.83%, with a transaction volume of 28.50 million yuan [6]. Group 3: Fund Performance and Flows - The Sci-Tech 100 Index ETF has seen a net inflow of 2.37 billion yuan over three days, with a peak single-day inflow of 122 million yuan [8]. - The fund's net asset value increased by 19.40% over the past six months, ranking it in the top 9.37% among similar funds [9]. - The ChiNext ETF has a historical return of 0.04% over the past five years, with a maximum monthly return of 37.39% since inception [11]. Group 4: Fund Characteristics - The management fee for the Sci-Tech 100 Index ETF is 0.15%, and the custody fee is 0.05%, which are among the lowest in its category [9]. - The tracking error for the Sci-Tech 100 Index ETF is 0.020%, indicating high tracking precision compared to similar funds [9]. - The top ten holdings of the Sci-Tech 100 Index account for 23.52% of the index, with companies like BoRui Pharmaceutical and BeiGene leading [10].